Medicine and Dentistry
Psychosis
100%
Dopamine
86%
Glutamic Acid
68%
Therapeutic Procedure
62%
Symptom
59%
Meta-Analysis
43%
Systematic Review
43%
Patient
41%
Dopamine Agonist
40%
Association
35%
Treatment-Resistant Schizophrenia
30%
Dopamine Metabolism
28%
Disease
26%
DOPA
25%
Brain
25%
Fluorine-18
24%
Clozapine
22%
Network Meta-Analysis
21%
Anterior Cingulate
20%
Psychosis
20%
Analysis
20%
Placebo
20%
Striatum
20%
Inpatient
19%
Proton Nuclear Magnetic Resonance
19%
Positron Emission Tomography
19%
Typical Antipsychotic
18%
Drug Therapy
18%
Magnetic Resonance Imaging
17%
Cingulate Cortex
16%
Negative Syndrome
16%
Depression
16%
Brain Imaging
16%
Neuroimaging
15%
Mental Stress
15%
Hippocampus
14%
Gray Matter
14%
Psychiatry
14%
Gene Locus
14%
Volunteer
13%
Chemotherapeutic Agent
12%
Drug
12%
Central Nervous System
11%
Pathophysiology
10%
Functional Magnetic Resonance Imaging
10%
Face
10%
Receptor
10%
Age
9%
Tetrahydrocannabinol
9%
Thalamus
9%
Neuroscience
Dopamine
98%
Dementia Praecox
95%
Meta-Analysis
86%
Psychosis
85%
Glutamic Acid
54%
Positron Emission Tomography
45%
Antipsychotic
30%
Dopaminergic
30%
Positron Emission Tomography
27%
Treatment-Resistant Schizophrenia
26%
Striatum
21%
In Vivo
18%
Eicosanoid Receptor
18%
Functional Connectivity
17%
Anterior Cingulate Cortex
16%
Nuclear Magnetic Resonance Spectroscopy
16%
Clozapine
15%
Brain Imaging
14%
Ethnicity
14%
Brain
13%
Placebo
12%
DOPA
12%
Magnetic Resonance Imaging
11%
Glucose
11%
Face
10%
Magnetic Resonance Imaging
10%
Amygdala
9%
Negative Syndrome
9%
Functional Magnetic Resonance Imaging
8%
Ventral Striatum
8%
Treatment of Schizophrenia
8%
Bipolar Disorder
8%
Depression
8%
Cholesterol
8%
High Density Lipoprotein Cholesterol
7%
Central Nervous System
7%
Lipid
7%
Propranolol
7%
Fusiform Gyrus
7%
Cannabinoid 1 Receptor
7%
Gene
7%
Methyldienolone
7%
Working Memory
7%
Dextro Aspartic Acid
7%
Microglia
7%
Naltrexone
7%
Memory
7%
Antidepressant
7%
Insulin
7%
Thalamus
7%
Pharmacology, Toxicology and Pharmaceutical Science
Schizophrenia
62%
Antipsychotic
45%
Symptom
29%
Clozapine
25%
Placebo
16%
Dopamine
15%
Treatment-Resistant Schizophrenia
15%
Psychosis
14%
Depression
8%
Diseases
8%
Dopamine Receptor Stimulating Agent
8%
Fluorine 18
8%
Negative Syndrome
7%
Positive Syndrome
7%
Adrenergic Receptor
7%
Randomized Clinical Trial
7%
Cannabinoid 1 Receptor
7%
DOPA
7%
Glutamic Acid
7%
Cohort Study
7%
Propranolol
7%
Therapeutic Use
7%
Ketamine
7%
Serotonin
7%